Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
25.37
-1.14 (-4.30%)
At close: Nov 20, 2026, 4:00 PM EST
25.42
+0.05 (0.20%)
After-hours: Nov 20, 2026, 7:30 PM EST
Alto Neuroscience Employees
Alto Neuroscience had 68 employees as of December 31, 2025. The number of employees decreased by 8 or 10.53% compared to the previous year. That makes Alto Neuroscience the 33,628th largest employer in the world and 4,400th in the United States.
Employees
68
Change (1Y)
-8
Growth (1Y)
-10.53%
Revenue / Employee
n/a
Profits / Employee
-$1,399,721
Market Cap
1.02B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | -8 | -10.53% |
| Dec 31, 2024 | 76 | 9 | 13.43% |
| Sep 30, 2024 | 88 | 27 | 44.26% |
| Jun 30, 2024 | 78 | 17 | 27.87% |
| Mar 31, 2024 | 67 | - | - |
| Sep 30, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 828 |
| Kardigan | 241 |
| Omeros | 175 |
| MoonLake Immunotherapeutics | 130 |
| Alpha Tau Medical | 121 |
| Inhibrx Biosciences | 110 |
| SpyGlass Pharma | 88 |
| Vor Biopharma | 76 |
ANRO News
- 2 days ago - Alto Neuroscience Transcript: Jefferies Global Healthcare Conference - Transcripts
- 10 days ago - Alto Neuroscience Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 10 days ago - Alto Neuroscience Slides: Investor presentation - Filings
- 10 days ago - Alto Neuroscience reports Q3 EPS (54c), consensus (72c) - TheFly
- 10 days ago - Alto Neuroscience Reports Third Quarter 2026 Financial Results and Recent Business Highlights - Business Wire
- 10 days ago - Alto Neuroscience Earnings release: Q3 2026 - Filings
- 10 days ago - Alto Neuroscience Quarterly report: Q3 2026 - Filings
- 17 days ago - Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - Business Wire